100% Operational in R3
- Since late 2017, a new environment has been created on an European level in the management of suspected adverse drug reactions: the new Eudravigilance.
- R2 software will become obsolete. Therefore, it is necessary to adapt systems, which involves migration of cases and the development of software in R3 environment, aligned with Eudravigilance.
- At Azierta, we have developed a new version of Vigilazierta, which is already validated and fully functional in R3, thereby complying with all the current EMA requirements.
ISO ICSR/ICH E2B R3 Compliance
MedDRA coding Integrated
Automatic report generation.
Technical support by IT and PV specialists.
R2 to R3 migration module
Signals Detection Module